Investors & Media 10-Q

SEC Filing Details

Document Details

Form
Filing Date
Feb 10, 2020
Document Date
Dec 31, 2019
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Axovant Gene Therapies
Issuer
Axovant Gene Therapies Ltd.